Actual dose achieved in 6-month intervals
| Dose . | First 6 months . | Second 6 months . | Third 6 months . | Fourth 6 months* . | ||||
|---|---|---|---|---|---|---|---|---|
| No. . | % . | No. . | % . | No. . | % . | No. . | % . | |
| 800 mg | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 45 | 43.4 |
| 700-799 mg | 0 | 0.0 | 3 | 2.9 | 37 | 35.9 | 7 | 6.8 |
| 600-699 mg | 60 | 58.3 | 67 | 65.0 | 29 | 28.2 | 20 | 19.4 |
| 500-599 mg | 19 | 18.4 | 10 | 9.7 | 12 | 11.7 | 5 | 4.9 |
| 400-499 mg | 15 | 14.6 | 8 | 7.8 | 7 | 6.8 | 6 | 5.8 |
| <400 mg | 4 | 3.9 | 3 | 2.9 | 2 | 1.9 | 3 | 2.9 |
| Dose . | First 6 months . | Second 6 months . | Third 6 months . | Fourth 6 months* . | ||||
|---|---|---|---|---|---|---|---|---|
| No. . | % . | No. . | % . | No. . | % . | No. . | % . | |
| 800 mg | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 45 | 43.4 |
| 700-799 mg | 0 | 0.0 | 3 | 2.9 | 37 | 35.9 | 7 | 6.8 |
| 600-699 mg | 60 | 58.3 | 67 | 65.0 | 29 | 28.2 | 20 | 19.4 |
| 500-599 mg | 19 | 18.4 | 10 | 9.7 | 12 | 11.7 | 5 | 4.9 |
| 400-499 mg | 15 | 14.6 | 8 | 7.8 | 7 | 6.8 | 6 | 5.8 |
| <400 mg | 4 | 3.9 | 3 | 2.9 | 2 | 1.9 | 3 | 2.9 |
The percentage is based on the 103 patients who commenced therapy with imatinib.
Average daily doses while remaining on protocol.